Entresto (Trade Name, With Valsartan Sodium); 4-[[(2S,4R)-5-Ethoxy-4-Methyl-5-Oxo-1-(4-Phenylphenyl)Pentan-2-Yl]Amino]-4-Oxobutanoic Acid; Ahu-377; 4-(((2S,4R)-1-([1,1'-Biphenyl]-4-Yl)-5-Ethoxy-4-Methyl-5-Oxopentan-2-Yl)Amino)-4-Oxobutanoic Acid; 4-(((2R,4R)-1-([1,1'-Biphenyl]-4-Yl)-5-Ethoxy-4-Methyl-5-Oxopentan-2-Yl)Amino)-4-Oxobutanoic Acid; (2R,4S)-5-(Biphenyl-4-Yl)-4-[(3-Carboxypropionyl)Amino]-2-Methylpentanoic Acid Ethyl Ester; (2R,4S)-5-([1,1'-Biphenyl]-4-Yl)-4-(3-Carboxypropanamido)-2-Methylpentanoic Acid; Ahu-377,149709-62-6; Ahu-37; Ahu377; Ahu 377

Brief Introduction

Sacubitril (INN developmental code name AHU-377) is an antihypertensive drug used in combination with valsartan. The combination drug valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name Entresto, is a treatment for heart failure. It was approved under the FDA's priority review process for use in heart failure on July 7, 2015.

Suppliers

View More Vendors (2） >

Liaoyuan Silver Eagle Pharmaceutical Co., Ltd.

Pharm Grade

25kg

Fibre Drum

Shandong Joyochem,Co.,Ltd.

≥99%

Travoprost

CAS:157283-68-6

Molecular Formula:C26H35F3O6

Alias

More Information

Fluprostenol Isopropyl Ester; Travatan; Travaprost; Flu-Ipr; (+)-9Alpha,11Alpha,15R-Trihydroxy-16-(3-(Trifluoromethyl)Phenoxy)-17,18,19,20-Tetranor-Prosta-5Z,13E-Dien-1-Oic Acid, Isopropyl Ester; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-Hydroxy-4-[3-(Trifluoromethyl)Phenoxy]-1-Buten-1-Yl]Cyclopentyl]-5-Heptenoic Acid 1-Methyethyl Ester; (+/-)-16-(M-Trifluoromethylphenoxy)Tetranorprostaglandin F2; 15(S)-Flu-Ipr; 15(S)-Fluprostenol Isopropyl Ester; 5-Heptenoic Acid, 7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-Hydroxy-4-[3-(Trifluoromethyl)Phenoxy]-1-Buten-1-Yl]Cyclopentyl]-, 1-Methylethyl Ester, (5Z)-; Propan-2-Yl (E)-7-[(1R,2S,3R,5S)-3,5-Dihydroxy-2-[(E)-3-Hydroxy-4-[3-(Trifluoromethyl)Phenoxy]But-1-Enyl]Cyclopentyl]Hept-5-Enoate; Trevostaglandin

Brief Introduction

It is used to reduce elevated intraocular pressure in patients with open-angle glaucoma or high intraocular pressure.

Suppliers

View More Vendors (2） >

Shanghai Chong Da Prostaglandin Fine Chemicals Co.,Ltd.

puirty:99%+

Gansu Haotian Pharmatech Co.,Ltd.

≥99%

Dutasteride

CAS:164656-23-9

Molecular Formula:C27H30F6N2O2

Alias

More Information

(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(Trifluoromethyl)Phenyl]-9a,11a-Dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-Dodecahydroindeno[5,4-f]Quinoline-1-Carboxamide; (5Alpha,17beta)-N-(2,5-Bis(Trifluoromethyl)Phenyl)-3-oxo-4-Azaandrost-1-ene-17-Carboxamide; Alpha,Alpha,Alpha,Alpha',Alpha',Alpha'-Hexafluoro-3-oxo-4-aza-5Alpha-Androst-1-ene-17beta-Carboxy-2',5'-Xylidide; Avodart; Duagen

Brief Introduction

Dutasteride is a new 5 α Dual inhibitor of reductase, used in patients with moderate and severe symptoms of benign prostatic hyperplasia

Suppliers

View More Vendors (2） >

Hubei Gedian Humanwell Pharmaceutical Co., Ltd.

CP/EP/USP

Pharm Grade

25kg

Fibre Drum

Hunan Yuxin Pharmaceutical Co., Ltd.

99%

Pharm Grade

25kg

Fibre Drum

Cabazitaxel

CAS:183133-96-2

Molecular Formula:C45H57NO14

Alias

More Information

Jevtana; Cabazitaxelum; Jevtana Kit; Kabazitaxel; Cabazitaxel (Jevtana)

Brief Introduction

Carbataxel combined with prednisone is used to treat hormone refractory metastatic prostate cancer previously treated with docetaxel containing regimen.

Suppliers

View More Vendors (2） >

Chongqing Beisheng Pharmaceutical Co.,Ltd.

≥99%

Pharm Grade

25kg

Fibre Drum

Shanghai Jinhe Bio-Pharmaceutical Co., Ltd.

99.0%

Pharm Grade

5kg

BOTTLE

Gliclazide

MSDS

CAS:21187-98-4

Molecular Formula:C15H21N3O3S

Alias

More Information

Glyzide; Diaprel; Diamicron; Glimicron; 1-[3-Azabicyclo[3.3.0]Oct-3-Yl]-3-P-Toluenesulfonylurea; 1-(3-Azabicyclo[3.3.0]Oct-3-Yl)-3-P-Tolylsulphonylurea; S-1702; Nordialex; S852; Glinormax; 1-(3-Azabicyclo(3.3.0)Oct-3-Yl)-3-(P-Tolylsulfonyl)Urea; 1-(Hexahydrocyclopenta(C)Pyrrol-2(1H)-Yl)-3-(P-Tolylsulfonyl)Urea; Benzenesulfonamide,N-(((Hexahydrocyclopenta(C)Pyrrol-2(1H)-Yl)Amino)Carbonyl; N-(4-Methylbenzenesulfonyl)-N'-(3-Azabicyclo(3.3.0)Oct-3-Yl)Urea; Tetrabenzyl Voglibose Hcl; Glicazeder

Brief Introduction

Gliclazide is the second generation of sulfonylurea oral hypoglycemic agents. It has both the hypoglycemic effect and the improvement of coagulation function. It can not only improve the metabolism of diabetic patients, but also improve or delay the occurrence of diabetic vascular complications. Developed by SERVIER, France, it was first listed in France in 1972. It is marketed as dacicam, methanesulfide, methanesulfide, bicyclic urea, Lai Keyi, methanesulfide and Glick NAC. It is mainly used for mild and medium II diabetes without onset of ketosis. It can also improve the fundus lesion and metabolism of diabetic patients. Vascular dysfunction. It can be combined with oral hypoglycemic agents of double guanidin and insulin in the treatment of insulin-dependent diabetes mellitus, which can reduce the dosage of insulin. It began to supply to China market in 1980s and has been registered and sold in more than 130 countries around the world.

Suppliers

View More Vendors (2） >

Shandong Haiyou Freda Pharmaceutical Co.,Ltd.